Dr Daskalakis explains revisions to the government budget rules that could have long-term impacts on scientific funding.
The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results